📣 VC round data is live. Check it out!
- Public Comps
- SD Biosensor
SD Biosensor Valuation Multiples
Discover SD Biosensor's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Mesa Laboratories, BrainsWay, Beta Bionics, Japan Lifeline and more.
SD Biosensor Overview
About SD Biosensor
SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing.
Founded
1999
HQ

Employees
N/A
Website
Financials (FY)
EV
$466M
Valuation Multiples
Start free trialSD Biosensor Financials
SD Biosensor reported last fiscal year revenue of $470M and negative EBITDA of ($447M).
In the same fiscal year, SD Biosensor generated $215M in gross profit, ($447M) in EBITDA losses, and had net loss of ($339M).
SD Biosensor P&L
In the most recent fiscal year, SD Biosensor reported revenue of $470M and EBITDA of ($447M).
SD Biosensor is unprofitable as of last fiscal year, with gross margin of 46%, EBITDA margin of (95%), and net margin of (72%).
Financial data powered by Morningstar, Inc.
SD Biosensor Stock Performance
SD Biosensor has current market cap of $590M, and enterprise value of $466M.
Market Cap Evolution
SD Biosensor's stock price is $4.94.
SD Biosensor share price decreased by 4.5% in the last 30 days, and by 29.8% in the last year.
SD Biosensor has an EPS (earnings per share) of $-2.83.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $466M | $590M | -0.6% | -4.5% | -4.9% | -29.8% | $-2.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSD Biosensor Valuation Multiples
SD Biosensor trades at 1.0x EV/Revenue multiple, and (1.0x) EV/EBITDA.
SD Biosensor Financial Valuation Multiples
As of June 3, 2026, SD Biosensor has market cap of $590M and EV of $466M.
SD Biosensor has a P/E ratio of (1.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SD Biosensor Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SD Biosensor Margins & Growth Rates
In the most recent fiscal year, SD Biosensor reported gross margin of 46%, EBITDA margin of (95%), and net margin of (72%).
SD Biosensor Margins
SD Biosensor Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SD Biosensor Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
SD Biosensor Competitors
SD Biosensor competitors include Mesa Laboratories, BrainsWay, Beta Bionics, Japan Lifeline, SI-BONE, NeuroPace, Sofwave Medical, Tactile Medical, Bioventus and Polynovo.
Most SD Biosensor public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.1x | 3.0x | 17.5x | 11.6x | |||
| 10.3x | 9.2x | 55.0x | 57.3x | |||
| 3.8x | 3.3x | (7.1x) | (5.9x) | |||
| 1.4x | 1.3x | 5.8x | 5.6x | |||
| 2.6x | 2.4x | 58.3x | 51.0x | |||
| 5.7x | 5.7x | (114.3x) | (86.6x) | |||
| 6.0x | - | 68.7x | - | |||
| 1.4x | 1.4x | 10.6x | 10.1x | |||
This data is available for Pro users. Sign up to see all SD Biosensor competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by SD Biosensor
SD Biosensor has acquired 1 company to date.
Last acquisition by SD Biosensor was on July 7th 2022. SD Biosensor acquired Meridian Bioscience for $2B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by SD Biosensor
| Description | Meridian Bioscience is a Cincinnati-headquartered life sciences company developing diagnostic tests for infectious diseases including gastrointestinal, respiratory, viral, and parasitic conditions. Operating in U.S. Diagnostics, European Diagnostics, and Life Science segments, it manufactures antigens, antibodies, PCR reagents, and contract biologics under cGMP standards. Products support clinical labs, researchers, and biopharma developers worldwide. |
| HQ Country | |
| HQ City | Cincinnati, OH |
| Deal Date | 7 Jul 2022 |
| Valuation | $2B |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all SD Biosensor acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by SD Biosensor
SD Biosensor has invested in 1 company to date.
Latest investment by SD Biosensor was on November 20th 2022. SD Biosensor invested in SD Biosensor in their $700K Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by SD Biosensor
| Description | SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing. |
| HQ Country | |
| HQ City | Suwon |
| Deal Date | 20 Nov 2022 |
| Round | Seed |
| Raised | $700K |
| Investors | SD Biosensor |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all SD Biosensor investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SD Biosensor
| When was SD Biosensor founded? | SD Biosensor was founded in 1999. |
| Where is SD Biosensor headquartered? | SD Biosensor is headquartered in South Korea. |
| Is SD Biosensor publicly listed? | Yes, SD Biosensor is a public company listed on Korea Exchange. |
| What is the stock symbol of SD Biosensor? | SD Biosensor trades under 137310 ticker. |
| When did SD Biosensor go public? | SD Biosensor went public in 2021. |
| Who are competitors of SD Biosensor? | SD Biosensor main competitors include Mesa Laboratories, BrainsWay, Beta Bionics, Japan Lifeline, SI-BONE, NeuroPace, Sofwave Medical, Tactile Medical, Bioventus, Polynovo. |
| What is the current market cap of SD Biosensor? | SD Biosensor's current market cap is $590M. |
| What is the current revenue of SD Biosensor? | SD Biosensor's last fiscal year revenue is $470M. |
| What is the current EV/Revenue multiple of SD Biosensor? | Current revenue multiple of SD Biosensor is 1.0x. |
| Is SD Biosensor profitable? | No, SD Biosensor is not profitable. |
| How many companies SD Biosensor has acquired to date? | As of June 2026, SD Biosensor has acquired 1 company. |
| What was the largest acquisition by SD Biosensor? | $2B acquisition of Meridian Bioscience on 7th July 2022 was the largest M&A SD Biosensor has done to date. |
| What companies SD Biosensor acquired? | SD Biosensor acquired Meridian Bioscience. |
| In how many companies SD Biosensor has invested to date? | As of June 2026, SD Biosensor has invested in 1 company. |
| What was the last SD Biosensor investment? | On 20th November 2022 SD Biosensor invested in SD Biosensor, participating in a $700K Seed round. |
| In what companies SD Biosensor invested in? | SD Biosensor invested in SD Biosensor. |
See public comps similar to SD Biosensor
Lists including SD Biosensor
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

